European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- ✦ Trusted Source

The Ph. Eur. monograph for tablets (0478) describes several test methods that manufacturers must use to evaluate the quality of their products. These test methods include:

The manufacturing process for tablets involves several steps, including:

“But manufacturing variability,” countered Luis, the production lead, “could spike scrap rates for legacy lines. Some suppliers can’t guarantee tighter granulation control without capital investment.”

Tablets must possess adequate mechanical strength to withstand handling, packaging, and shipping without crumbling. Manufacturers verify this through dedicated tests found in and Chapter 2.9.8 (Resistance to Crushing) . 2. Subdivision of Scored Tablets European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

: Uncoated tablets containing acid substances and carbonates that react quickly in water to release carbon dioxide.

According to the monograph, tablets are solid preparations, each containing a single dose of one or more active substances. They are primarily obtained by compressing uniform volumes of particles but can also be manufactured via extrusion, moulding, or freeze-drying (lyophilisation).

Dissolution testing evaluates the rate at which the API is released from the tablet matrix into a liquid medium, simulating human physiological conditions. This is a critical surrogate marker for in vivo drug absorption and bioavailability. Modified-release and gastro-resistant tablets require highly specialized dissolution profiles (e.g., testing in acid medium followed by a buffer change). C. Disintegration (2.9.1) The Ph

Once produced, the finished products must satisfy precise, standardized QC testing protocols prior to release:

Measures the weight lost when tablets are tumbled in a rotating drum. A loss of less than 1% is generally required.

Do you need a comparison between standards? Are you interested in the latest 11th Edition updates ? Share public link These test methods include: The manufacturing process for

While not always a specific limit in the monograph, hardness is a critical in-process control (IPC). The tablet must be hard enough to handle but soft enough to disintegrate/dissolve.

Monograph 0478 states that impurities come from two sources:

To comply with Ph. Eur. 0478, tablets must pass a rigorous battery of tests. These tests ensure that the physical characteristics of the tablet translate into reliable therapeutic performance. 1. Uniformity of Dosage Units

The document read like a recipe and a contract. Definitions, nomenclature, identity tests, uniformity, dissolution — each heading framed a patient’s expectation. The monograph did not dictate production methods; instead it set measurable thresholds and validated analytical procedures. Complying with it meant a tablet that would behave as intended from factory line to bedside.

Monograph 0478, Tablets , is a general monograph in the European Pharmacopoeia (Ph. Eur.) that lays down mandatory quality standards for all solid oral dosage forms defined as tablets. It applies to uncoated, film-coated, and sugar-coated tablets, unless otherwise specified in an individual monograph.